Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Administration of CD34+ cells after stroke enhances neurogenesis via angiogenesisin a mouse model
Akihiko Taguchi, … , Hiroaki Naritomi, Tomohiro Matsuyama
Akihiko Taguchi, … , Hiroaki Naritomi, Tomohiro Matsuyama
Published August 1, 2004
Citation Information: J Clin Invest. 2004;114(3):330-338. https://doi.org/10.1172/JCI20622.
View: Text | PDF
Article Cardiology

Administration of CD34+ cells after stroke enhances neurogenesis via angiogenesisin a mouse model

  • Text
  • PDF
Abstract

Thrombo-occlusive cerebrovascular disease resulting in stroke and permanent neuronal loss is an important cause of morbidity and mortality. Because of the unique properties of cerebral vasculature and the limited reparative capability of neuronal tissue, it has been difficult to devise effective neuroprotective therapies in cerebral ischemia. Our results demonstrate that systemic administration of human cord blood–derived CD34+ cells to immunocompromised mice subjected to stroke 48 hours earlier induces neovascularization in the ischemic zone and provides a favorable environment for neuronal regeneration. Endogenous neurogenesis, suppressed by an antiangiogenic agent, is accelerated as a result of enhanced migration of neuronal progenitor cells to the damaged area, followed by their maturation and functional recovery. Our data suggest an essential role for CD34+ cells in promoting directly or indirectly an environment conducive to neovascularization of ischemic brain so that neuronal regeneration can proceed.

Authors

Akihiko Taguchi, Toshihiro Soma, Hidekazu Tanaka, Takayoshi Kanda, Hiroyuki Nishimura, Hiroo Yoshikawa, Yoshitane Tsukamoto, Hiroyuki Iso, Yoshihiro Fujimori, David M. Stern, Hiroaki Naritomi, Tomohiro Matsuyama

×

Figure 7

Options: View larger image (or click on image) Download as PowerPoint
CD34+ cell transplantation in 24-week-old animals. (A–C) On day 35 after...
CD34+ cell transplantation in 24-week-old animals. (A–C) On day 35 after cell transplantation, the brains were evaluated. Compared with poststroke mice treated with CD34– cells (A), animals transplanted with CD34+ cells (B) showed an increase in area occupied by the left cortex. Significant cortical regeneration was induced by CD34+ cells transplantation (C). (D and E) Compared with CD34– cell transplantation (D), increased evidence of activated vasculature was observed in animals receiving CD34+ cells (E), as detected with mouse specific anti-CD13 antibody. (F–H) Migration of NPCs (small NeuN+ nuclei migrating toward the cortex) was observed in poststroke mice treated with CD34– cells (F) and with CD34+ cells (G). However, a significant increase in migrating NPCs was induced by CD34+ cell transplantation (H). (I and J) A thin layer of migrating PSA-NCAM+ NPCs was observed at the ischemic edge of the cortex in animals treated with CD34– cells (I), compared with a much thicker layer in those receiving CD34+ cells (J). Scale bars: 2 mm (A), 0.1 mm (D and I), and 0.4 mm (F). n = 4 in each group; *P < 0.05 versus CD34– cells.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts